Frequency, risk factors, and clinical outcomes of left ventricular assist device-associated ventricular thrombus

Authors
Reilly, MP Wiegers, SE Cucchiara, AJ O'Hara, ML Plappert, TJ Loh, E Acker, MA Sutton, NS
Citation
Mp. Reilly et al., Frequency, risk factors, and clinical outcomes of left ventricular assist device-associated ventricular thrombus, AM J CARD, 86(10), 2000, pp. 1156
Citations number
18
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF CARDIOLOGY
ISSN journal
00029149 → ACNP
Volume
86
Issue
10
Year of publication
2000
Database
ISI
SICI code
0002-9149(20001115)86:10<1156:FRFACO>2.0.ZU;2-1
Abstract
A retrospective, transesophageal study of 51 consecutive patients receiving a left ventricular (LV) assist device (AD) over a 2-year period showed tha t LVAD-associated LV thrombosis (16%) was predicted by acute myocardial inf arction, atrial cannulation, and postimplantation bleeding, and was associa ted with a fourfold increased risk of stroke compared with patients without thrombosis. LV cannulation, when using short-term LVADs, may decrease the incidence of LV thrombosis, and early transition to Heartmate-LVAD support may improve outcome.